Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,100 | 3 | 37.9% |
| Consulting Fee | $2,035 | 3 | 36.8% |
| Food and Beverage | $1,309 | 56 | 23.7% |
| Education | $92.33 | 3 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eko Devices, Inc. | $4,000 | 4 | $0 (2022) |
| Astellas Pharma US Inc | $291.08 | 16 | $0 (2023) |
| ABBVIE INC. | $265.24 | 9 | $0 (2022) |
| Novo Nordisk Inc | $179.99 | 8 | $0 (2021) |
| Daiichi Sankyo Inc. | $125.00 | 1 | $0 (2021) |
| MAYNE PHARMA INC. | $125.00 | 1 | $0 (2022) |
| Eko Health, Inc. | $100.00 | 1 | $0 (2023) |
| Channel Medsystems, Inc. | $70.63 | 1 | $0 (2022) |
| Allergan Inc. | $65.90 | 4 | $0 (2019) |
| TherapeuticsMD, Inc. | $54.60 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $161.95 | 2 | Eko Health, Inc. ($100.00) |
| 2022 | $4,275 | 10 | Eko Devices, Inc. ($4,000) |
| 2021 | $240.23 | 7 | Daiichi Sankyo Inc. ($125.00) |
| 2020 | $154.70 | 11 | Astellas Pharma US Inc ($50.00) |
| 2019 | $333.44 | 17 | Novo Nordisk Inc ($115.57) |
| 2018 | $268.88 | 11 | AbbVie, Inc. ($120.24) |
| 2017 | $102.14 | 7 | Astellas Pharma US Inc ($34.27) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/20/2023 | Eko Health, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $100.00 | General |
| 03/16/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $61.95 | General |
| 11/17/2022 | Channel Medsystems, Inc. | — | Food and Beverage | Cash or cash equivalent | $70.63 | General |
| 09/13/2022 | Medtronic, Inc. | LAPRO-CLIP (Device) | Consulting Fee | Cash or cash equivalent | $35.00 | General |
| Category: Hand Instruments and Ligation Devices | ||||||
| 08/18/2022 | Eko Devices, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 07/28/2022 | Eko Devices, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| 07/09/2022 | Eko Devices, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 06/13/2022 | Eko Devices, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| 05/11/2022 | ABBVIE INC. | ORILISSA (Drug), LO LOESTRIN FE | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: WOMENS HEALTH | ||||||
| 05/05/2022 | Myovant Sciences Inc. | MYFEMBREE (Drug) | Education | In-kind items and services | $16.35 | General |
| Category: HORMONE THERAPY | ||||||
| 03/28/2022 | ABBVIE INC. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: WOMENS HEALTH | ||||||
| 02/17/2022 | MAYNE PHARMA INC. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 05/24/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Obesity | ||||||
| 05/20/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Iron Deficiency Anemia | ||||||
| 02/23/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: UROLOGY | ||||||
| 02/03/2021 | Hologic, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Diagnostics | ||||||
| 01/26/2021 | AbbVie Inc. | ORIAHNN (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: WOMENS HEALTH | ||||||
| 01/20/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: UROLOGY | ||||||
| 01/04/2021 | AbbVie Inc. | ORILISSA (Drug), ORIAHNN | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: WOMENS HEALTH | ||||||
| 11/19/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: UROLOGY | ||||||
| 10/22/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Obesity | ||||||
| 10/07/2020 | Ethicon US, LLC | STRATAFIX (Device), Surgicel Powder | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Wound Closure | ||||||
| 09/08/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: UROLOGY | ||||||
| 08/24/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Obesity | ||||||
| 08/19/2020 | CooperSurgical, Inc. | Endosee (Device) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Obstetrics/Gynecology (Women's Health) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 72 | 149 | $24,750 | $11,867 |
| 2022 | 7 | 149 | 231 | $44,384 | $16,672 |
| 2021 | 7 | 231 | 280 | $50,417 | $19,109 |
| 2020 | 9 | 936 | 997 | $172,690 | $63,571 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 131 | $23,580 | $11,214 | 47.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 18 | 18 | $1,170 | $653.76 | 55.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 126 | $22,680 | $9,624 | 42.4% |
| 77067 | Screening mammography | Office | 2022 | 28 | 28 | $9,100 | $3,304 | 36.3% |
| 77063 | Screening 3d breast mammography | Office | 2022 | 27 | 27 | $4,050 | $1,330 | 32.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 14 | $3,080 | $1,093 | 35.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 13 | 13 | $845.00 | $476.09 | 56.3% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 12 | 12 | $504.00 | $473.88 | 94.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 11 | 11 | $4,125 | $370.64 | 9.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 38 | 80 | $14,180 | $6,769 | 47.7% |
| 77067 | Screening mammography of both breasts | Office | 2021 | 46 | 46 | $14,950 | $5,577 | 37.3% |
| 77063 | Screening digital tomography of both breasts | Office | 2021 | 45 | 45 | $6,750 | $2,309 | 34.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 31 | 31 | $1,302 | $1,247 | 95.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 23 | $2,530 | $1,226 | 48.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 32 | 32 | $2,080 | $1,181 | 56.8% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 23 | 23 | $8,625 | $802.24 | 9.3% |
| 77067 | Mammography of both breasts | Office | 2020 | 225 | 225 | $73,125 | $28,310 | 38.7% |
| 77063 | Screening digital tomography of both breasts | Office | 2020 | 225 | 225 | $33,750 | $11,636 | 34.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 164 | 220 | $24,200 | $9,506 | 39.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 138 | 138 | $8,970 | $5,264 | 58.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 38 | 41 | $6,560 | $2,951 | 45.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 65 | 65 | $2,730 | $2,614 | 95.7% |
| 77080 | Bone density measurement using dedicated x-ray machine | Office | 2020 | 47 | 47 | $17,625 | $1,703 | 9.7% |
| 76830 | Ultrasound pelvis through vagina | Office | 2020 | 14 | 14 | $4,200 | $1,077 | 25.7% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 20 | 22 | $1,530 | $509.45 | 33.3% |
About Dr. James Eaker, MD
Dr. James Eaker, MD is a Obstetrics & Gynecology healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346219284.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Eaker, MD has received a total of $5,537 in payments from pharmaceutical and medical device companies, with $161.95 received in 2023. These payments were reported across 65 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($2,100).
As a Medicare-enrolled provider, Eaker has provided services to 1,388 Medicare beneficiaries, totaling 1,657 services with total Medicare billing of $111,220. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Augusta, GA
- Active Since 03/14/2006
- Last Updated 04/09/2013
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1346219284
Products in Payments
- Saxenda (Drug) $179.99
- INJECTAFER (Drug) $125.00
- Lupron (Drug) $120.24
- VESICARE (Drug) $106.88
- MYRBETRIQ (Drug) $87.98
- Orilissa (Drug) $78.11
- LO LOESTRIN FE (Drug) $69.59
- IMVEXXY (Drug) $42.52
- ORILISSA (Drug) $35.61
- LAPRO-CLIP (Device) $35.00
- Myrbetriq (Drug) $34.27
- Aptima HPV (Device) $29.01
- Kyleena (Drug) $26.20
- APTIMA (Device) $21.13
- BD Affirm (Device) $19.77
- MYFEMBREE (Drug) $16.35
- ORIAHNN (Drug) $15.91
- INTRAROSA (Drug) $14.03
- Endosee (Device) $13.71
- Prolia (Biological) $13.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Augusta
Dr. Murray Freedman, Md, MD
Obstetrics & Gynecology — Payments: $93,805
Michael Rausch, M.d, M.D
Obstetrics & Gynecology — Payments: $89,995
Dr. C Chance, Md, MD
Obstetrics & Gynecology — Payments: $12,152
Dr. Hatim Lukman, Md, MD
Obstetrics & Gynecology — Payments: $8,395
Dr. Donald Burns, Md, MD
Obstetrics & Gynecology — Payments: $7,924
Dr. William Barfield, Md, MD
Obstetrics & Gynecology — Payments: $6,830